{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/66bac3f1b52bf387545b07ed?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Tuesday, August 13, 2024","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1723515819964-be3359a7-ed43-4cd5-9541-859c50189488.jpeg?height=200","description":"<p>A medical journal retracts three papers on MDMA-assisted psychotherapy following the FDA’s rejection of the treatment. CMS outlines updates for its ACO REACH model for 2025.&nbsp;And the DOJ finalizes a rule to improve access to medical care for people with disabilities. That’s coming up on today’s episode of Gist Healthcare Daily.&nbsp;</p>","author_name":"Gist Healthcare Daily"}